https://www.pharmanow.live/latest-news/fosun-pharma-hk1-billion-h-share-buyback-gland-pharma-stake-disposal 2026-09-07T11:07:28+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Fosun Pharma Secures HK$1B H-Share Buyback via Gland Stake Sale Fosun Pharma https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e0d7c157-6648-4d52-b1b0-68ccb7465d87/73c05041-e792-48a1-a87c-2a6549866623.png https://www.pharmanow.live/latest-news/indian-immunologicals-abhayrab-quality-dispute-cdsco-batch-records 2026-09-07T11:07:07+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Indian Immunologicals Disputes Abhayrab Findings, Submits Records Indian Immunologicals https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e0d7c157-6648-4d52-b1b0-68ccb7465d87/6f0e8972-e93a-480e-8821-a8be9374f779.png https://www.pharmanow.live/latest-news/rezubio-fda-nmpa-ind-clearances-rz-520-chronic-respiratory-disease 2026-09-07T11:07:03+05:30 Pharma Now en 2026-09-07T00:00:00+05:30 Rezubio Gains FDA, NMPA IND Clearances for Inhaled RZ-520 Rezubio https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/e0d7c157-6648-4d52-b1b0-68ccb7465d87/015acb19-2ccf-41f2-82c1-68f1b4208c91.png https://www.pharmanow.live/latest-news/data-integrity-not-scale-is-indias-real-competitive-advantage-chakravarthi-avps-on-indias-pharma-leadership-at-gpacts-2026 2026-09-05T10:45:16+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 Data Integrity, Not Scale, Is India's Real Competitive Advantage - Chakravarthi AVPS on India's Pharma Leadership at GPACTS 2026 GPACTS 2026, Chakravarthi AVPS, data integrity, pharma IT, ALCOA+, FDA compliance, AI in pharma manufacturing, serialization, Pharma Now, YellowHive Events & Media https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/chakravarthi_avps_keynote_press_release20260905101217.png https://www.pharmanow.live/latest-news/fda-emergency-compounding-guidance-neonatal-parenteral-nutrition-outsourcing-facility-shutdown 2026-09-07T11:44:24+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 FDA Issues Emergency Guidance After Neonatal PN Supply Shutdowns FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fda-emergency-compounding-guidance-neonatal-nutrition20260907114406.webp https://www.pharmanow.live/latest-news/novartis-pelacarsen-fails-phase-iii-lpa-horizon-cardiovascular-outcomes-trial 2026-09-07T11:53:27+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 Novartis Pelacarsen Fails Phase III Lp(a) Trial Novartis https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/novartis-pelacarsen-phase-iii-cardiovascular-trial-fails20260907115223.webp https://www.pharmanow.live/latest-news/astrazeneca-fda-accelerated-approval-camizestrant-esr1-mutation-breast-cancer 2026-09-07T12:09:16+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 AstraZeneca Wins FDA Approval for Camizestrant in Breast Cancer AstraZeneca https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/astrazeneca-fda-accelerated-approval-camizestrant-breast-cancer20260907120856.webp https://www.pharmanow.live/latest-news/astrazeneca-fda-accelerated-approval-camizestrant-cdk46-esr1-mutated-breast-cancer 2026-09-07T12:17:06+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 AstraZeneca Wins FDA Accelerated Nod for Camizestrant AstraZeneca https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/astrazeneca-fda-accelerated-approval-camizestrant-breast-cancer20260907121652.webp https://www.pharmanow.live/latest-news/fda-flags-zubb-dietary-supplement-hidden-sildenafil-weight-loss 2026-09-05T10:50:00+05:30 Pharma Now en 2026-09-05T00:00:00+05:30 FDA Flags ZUBB Supplement for Hidden Sildenafil FDA https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/agents-data/images/news/98af20de-8ff4-46c1-980d-23944177d232/cf9eb7bb-35d1-4a26-aed2-bd9cbd255283.png